Weighted Average Number of Shares Outstanding, Basic of Arbutus Biopharma Corp from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Arbutus Biopharma Corp quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Arbutus Biopharma Corp Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 191,778,950, a 1.5% increase year-over-year.
  • Arbutus Biopharma Corp annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 185,608,874, a 12% increase from 2023.
  • Arbutus Biopharma Corp annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 165,960,379, a 10% increase from 2022.
  • Arbutus Biopharma Corp annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 150,939,337, a 42% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Arbutus Biopharma Corp Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 191,778,950 +2,781,756 +1.5% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 191,551,282 +3,509,793 +1.9% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 190,707,085 +15,081,533 +8.6% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 185,608,874 +19,648,495 +12% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 188,997,194 +21,484,486 +13% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 188,041,489 +21,978,205 +13% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 175,625,552 +13,982,148 +8.6% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 165,960,379 +15,021,042 +10% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 167,512,708 +16,517,517 +11% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 166,063,284 +17,313,236 +12% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 161,643,404 +13,215,078 +8.9% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 150,939,337 +44,696,885 +42% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 150,995,191 +49,708,840 +49% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 148,750,048 +51,880,243 +54% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 148,428,326 +54,993,948 +59% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 106,242,452 +30,407,074 +40% 01 Oct 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 101,286,351 +21,798,907 +27% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 96,869,805 +27,265,079 +39% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 93,434,378 +25,750,792 +38% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 75,835,378 01 Oct 2020 31 Dec 2020 10-K 03 Mar 2022 2021 FY
Q3 2020 79,487,444 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 69,604,726 +12,799,143 +23% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 67,683,586 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q2 2019 56,805,583 +1,594,289 +2.9% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q2 2018 55,211,294 +563,350 +1% 01 Apr 2018 30 Jun 2018 10-Q 05 Aug 2019 2019 Q2
Q2 2017 54,647,944 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2018 2018 Q2
Q1 2015 30,208,136 +10,406,708 +53% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q1 2014 19,801,428 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015 2015 Q1

Arbutus Biopharma Corp Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 185,608,874 +19,648,495 +12% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 165,960,379 +15,021,042 +10% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 150,939,337 +44,696,885 +42% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
2021 106,242,452 +30,407,074 +40% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
2020 75,835,378 01 Jan 2020 31 Dec 2020 10-K 03 Mar 2022 2021 FY
2018 55,304,083 +580,811 +1.1% 01 Jan 2018 31 Dec 2018 10-K 07 Mar 2019 2018 FY
2017 54,723,272 +1,648,871 +3.1% 01 Jan 2017 31 Dec 2017 10-K 07 Mar 2019 2018 FY
2016 53,074,401 +7,612,077 +17% 01 Jan 2016 31 Dec 2016 10-K 16 Mar 2018 2017 FY
2015 45,462,324 +23,859,188 +110% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018 2017 FY
2014 21,603,136 +6,300,456 +41% 01 Jan 2014 31 Dec 2014 10-K 22 Mar 2017 2016 FY
2013 15,302,680 +1,574,755 +11% 01 Jan 2013 31 Dec 2013 10-K 09 Mar 2016 2015 FY
2012 13,727,925 +2,409,159 +21% 01 Jan 2012 31 Dec 2012 10-K 13 Mar 2015 2014 FY
2011 11,318,766 +985,825 +9.5% 01 Jan 2011 31 Dec 2011 10-K 28 Mar 2014 2013 FY
2010 10,332,941 01 Jan 2010 31 Dec 2010 20-F 27 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.